Catalyst Wire Dossier Catalyst Wire Dossier

N-Methanocarbathymidine

N-Methanocarbathymidine · N&N Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N-Methanocarbathymidine, covering 2016-09-22 to 2016-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients [Phase 1]

See pricing